You read it in the news headlines. You see it across social media. You hear in healthcare conferences and press conferences alike. It seems like everyone is talking about it. No, it’s not the latest meme or viral trend; it’s the concerning uptick in...
Cardiovascular disease (CVD) is all around us. Whether you’ve been warned by a healthcare provider that your LDL levels are too high, or a loved one has experienced a heart attack or stroke, many of us have been touched in some way by the disease....
In Part One of the blog series, I reviewed CKD statistics and associated costs and began to touch on opportunities to identify those at substantial risk or those who could have damage to their kidneys already. With that background, we can explore...
With the hustle and bustleof our 2024 Annual User Conference behind us, time has been passing very quickly this Spring here at Azara—and with Spring comes seasonal allergies and pollen, which are just two of the many asthma triggers. Just in time...
According to the National Institute of Health, chronic kidney disease (CKD) is common in adults in the US, with more than 37 million American adults living with the disease1. In advanced stages, CKD can...
Well, here we are, two weeks into May (don’t blink or you might miss it!), and well into the UDS+ Calendar Year 2023 (CY23) voluntary submissions. In case you missed it, on March 26th Azara became the first vendor to successfully submit data to HRSA...
